Hikma Pharmaceuticals PLC
Abrir
SetorSaúde
1,474 -0.81
Visão Geral
Variação de preço das ações
24h
Mín
1469
Máximo
1491
Rendimento | 165M |
|---|---|
Vendas | 41M 1.7B |
P/E Médio do Setor | 10.771 49.052 |
EPS | 1.07 |
Rendimento de Dividendos | 5.74 |
Margem de lucro | 9.698 |
Funcionários | 9,400 |
EBITDA | 152M 411M |
Recomendações | Comprar |
|---|---|
Previsão para 12 meses | +23.99% upside |
Rendimento de Dividendos Médio do Setor | 5.74% 2.36% |
|---|---|
Próximos Ganhos | 6 de ago. de 2026 |
Próxima data de ex-dividendo | 13 de ago. de 2026 |
Capitalização de Mercado | -526M 3.1B |
|---|---|
Abertura anterior | 1474.81 |
Fecho anterior | 1474 |
Sentimento de Notícias
By Acuity
43%
57%
118 / 342 Ranking em Healthcare
Hikma Pharmaceuticals PLC Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Sobre Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.